Peer review reports
From: EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Original Submission | ||
---|---|---|
14 Jun 2021 | Submitted | Original manuscript |
21 Jan 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 2 | ||
21 Jan 2022 | Submitted | Manuscript version 2 |
7 Feb 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 3 | ||
7 Feb 2022 | Submitted | Manuscript version 3 |
23 Feb 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 4 | ||
23 Feb 2022 | Submitted | Manuscript version 4 |
22 Mar 2022 | Reviewed | Reviewer Report |
30 Mar 2022 | Reviewed | Reviewer Report |
1 Jul 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 5 | ||
1 Jul 2022 | Submitted | Manuscript version 5 |
1 Jul 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 6 | ||
1 Jul 2022 | Submitted | Manuscript version 6 |
1 Sep 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 7 | ||
1 Sep 2022 | Submitted | Manuscript version 7 |
9 Sep 2022 | Author responded | Author comments - Stefan Gröschel |
Resubmission - Version 8 | ||
9 Sep 2022 | Submitted | Manuscript version 8 |
Publishing | ||
16 Sep 2022 | Editorially accepted | |
5 Oct 2022 | Article published | 10.1186/s12885-022-10109-1 |